Clinical trialNCT03561259UnknownPhase 2Interventional

A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects

SponsorJubilant DraxImage Inc.Enrollment60NeoplasmsNeuroblastomaNeuroectodermal Tumors

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the efficacy and safety of 131I-MIBG in combination with Vorinostat in patients with Recurrent or Progressive neuroblastoma

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Melda Dolan
Jubilant DraxImage Inc., dba Jubilant Radiopharma
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Stanford University
Palo Alto, California, United States
Robbie Majzner, MD
Not, yet, recruiting
Ucsf Pediatric Hematology/oncology
San Francisco, California, United States
Kieuhoa Vo, MD
Recruiting
Children'S Hospital Colorado
Aurora, Colorado, United States
Margaret Macy, MD
Recruiting
Nemours Children'S Specialty Care
Jacksonville, Florida, United States
Manisha Bansal, MD
Recruiting
University of Chicago Medical Center
Chicago, Illinois, United States
Ami V Desai, MD
Recruiting
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
David Dickens, MD
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Suzanne Shusterman, MD
Recruiting
University of Minnesota
Minneapolis, Minnesota, United States
Emily Greengard, MD
Recruiting
Washington University Medical Center in St. Louis
St Louis, Missouri, United States
Frederick Huang, MD
Recruiting
Northwell Health /cohen Children'S Medical Center
New Hyde Park, New York, United States
Julie Krystal, MD
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Ellen Basu, MD, PhD
Recruiting
Carolinas Medical Center/levine Children'S Hospital (atrium Health)
Charlotte, North Carolina, United States
Javier E Osterheld, MD
Recruiting
Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Brian Weiss, MD
Recruiting
the Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Yael Mosse, MD
Recruiting
Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Andrew Bukowinski, MD
Recruiting
Upmc Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Andrew Bukowinski, MD
Recruiting
University of Texas Southwestern Medical Center, Children'S Health
Dallas, Texas, United States
Tanya Watt, MD
Recruiting
Cook Children'S Hematology/oncology Center
Fort Worth, Texas, United States
Meaghan Granger, MD
Recruiting
Texas Children'S Hospital
Houston, Texas, United States
Jennifer Foster, MD
Recruiting
Seattle Children'S Hospital
Seattle, Washington, United States
Navin R Pinto, MD
Recruiting
University of Wisconsin, American Family Children'S Hospital and Clinical Science Center
Madison, Wisconsin, United States
Kenneth DeSantes, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

131-MIBG + Vorinostat131I-MIBG

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 21 Oct 2019
Primary completion: 1 Dec 2023
Completion: 30 Apr 2025
Last update posted: 16 Feb 2023
Registered enrollment: 60
Registry id: NCT03561259

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.